Published in Oncogene on October 30, 2006
A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell (2009) 4.98
Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev (2009) 4.55
Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol (2010) 3.30
Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta (2010) 2.55
Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One (2007) 2.18
Molecular basis of NF-κB signaling. Annu Rev Biophys (2013) 2.03
p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol (2009) 1.83
Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem (2008) 1.78
Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. J Virol (2007) 1.68
Modulation of NF-κB signalling by microbial pathogens. Nat Rev Microbiol (2011) 1.64
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism. PLoS Pathog (2009) 1.50
RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages. PLoS Pathog (2008) 1.49
Emerging roles for the non-canonical IKKs in cancer. Oncogene (2010) 1.48
NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J Virol (2008) 1.38
Co-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013. PLoS Pathog (2009) 1.32
NF-κB in Aging and Disease. Aging Dis (2011) 1.28
Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy. Proc Natl Acad Sci U S A (2011) 1.27
HIV-1 activates macrophages independent of Toll-like receptors. PLoS One (2008) 1.26
The NFκB pathway: a therapeutic target in glioblastoma. Oncotarget (2011) 1.25
Viral evasion of autophagy. Autophagy (2007) 1.23
Proteasome-independent degradation of canonical NFkappaB complex components by the NleC protein of pathogenic Escherichia coli. J Biol Chem (2010) 1.21
Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol (2007) 1.20
Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response. PLoS Pathog (2013) 1.15
Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication. PLoS Pathog (2010) 1.14
Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J Virol (2012) 1.14
The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol (2007) 1.13
Viral mediated redirection of NEMO/IKKγ to autophagosomes curtails the inflammatory cascade. PLoS Pathog (2012) 1.11
Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J (2009) 1.11
Identification of differentially expressed miRNAs in chicken lung and trachea with avian influenza virus infection by a deep sequencing approach. BMC Genomics (2009) 1.05
The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity. J Virol (2011) 1.05
HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1). PLoS Pathog (2010) 1.01
Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization. Virology (2012) 0.97
The shrimp NF-κB pathway is activated by white spot syndrome virus (WSSV) 449 to facilitate the expression of WSSV069 (ie1), WSSV303 and WSSV371. PLoS One (2011) 0.96
UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS. Cell Rep (2013) 0.95
Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy. J Virol (2013) 0.95
A novel inhibitor of the NF-{kappa}B signaling pathway encoded by the parapoxvirus orf virus. J Virol (2010) 0.94
The MC159 protein from the molluscum contagiosum poxvirus inhibits NF-κB activation by interacting with the IκB kinase complex. J Immunol (2012) 0.94
Influenza virus and cell signaling pathways. Med Sci Monit (2011) 0.93
Collaboration of Toll-like and RIG-I-like receptors in human dendritic cells: tRIGgering antiviral innate immune responses. Am J Clin Exp Immunol (2013) 0.92
Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques. PLoS One (2011) 0.91
A role for NRAGE in NF-kappaB activation through the non-canonical BMP pathway. BMC Biol (2010) 0.91
Porcine epidemic diarrhea virus nucleocapsid protein antagonizes beta interferon production by sequestering the interaction between IRF3 and TBK1. J Virol (2014) 0.91
Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses. J Virol (2007) 0.90
Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression. J Virol (2008) 0.90
The TRAIL to viral pathogenesis: the good, the bad and the ugly. Curr Mol Med (2009) 0.89
Characterization of the core elements of the NF-κB signaling pathway of the sea anemone Nematostella vectensis. Mol Cell Biol (2010) 0.89
Walleye dermal sarcoma virus rv-cyclin inhibits NF-kappaB-dependent transcription. Virology (2009) 0.84
Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection. Virology (2008) 0.84
The human cytomegalovirus UL26 protein antagonizes NF-κB activation. J Virol (2014) 0.83
Impact of mosquito bites on asexual parasite density and gametocyte prevalence in asymptomatic chronic Plasmodium falciparum infections and correlation with IgE and IgG titers. Infect Immun (2012) 0.83
Novel Phosphorylations of IKKγ/NEMO. MBio (2012) 0.82
Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65. J Virol (2014) 0.82
Poxviral ankyrin proteins. Viruses (2015) 0.82
Murine cytomegalovirus virion-associated protein M45 mediates rapid NF-κB activation after infection. J Virol (2014) 0.82
Infection-Induced Retrotransposon-Derived Noncoding RNAs Enhance Herpesviral Gene Expression via the NF-κB Pathway. PLoS Pathog (2015) 0.80
Commensal microflora induce host defense and decrease bacterial translocation in burn mice through toll-like receptor 4. J Biomed Sci (2010) 0.80
A vaccinia virus deletion mutant reveals the presence of additional inhibitors of NF-kappaB. J Virol (2010) 0.80
Early viral protein synthesis is necessary for NF-kappaB activation in modified vaccinia Ankara (MVA)-infected 293 T fibroblast cells. Virology (2009) 0.80
The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation. Nat Commun (2015) 0.80
Ccr5 regulates inflammatory gene expression in response to encephalomyocarditis virus infection. Am J Pathol (2011) 0.80
Gut flora enhance bacterial clearance in lung through toll-like receptors 4. J Biomed Sci (2011) 0.80
The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells. Virology (2013) 0.80
EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence. PLoS Pathog (2014) 0.80
Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. Nat Immunol (2016) 0.80
The shrimp IKK-NF-κB signaling pathway regulates antimicrobial peptide expression and may be subverted by white spot syndrome virus to facilitate viral gene expression. Cell Mol Immunol (2013) 0.79
Probing the Solution Structure of IκB Kinase (IKK) Subunit γ and Its Interaction with Kaposi Sarcoma-associated Herpes Virus Flice-interacting Protein and IKK Subunit β by EPR Spectroscopy. J Biol Chem (2015) 0.78
NF-κB activation coordinated by IKKβ and IKKε enables latent infection of Kaposi's sarcoma-associated herpesvirus. J Virol (2013) 0.78
Human T cell leukaemia virus type 2 tax protein mediates CC-chemokine expression in peripheral blood mononuclear cells via the nuclear factor kappa B canonical pathway. Clin Exp Immunol (2014) 0.78
The role of IKKβ in Venezuelan equine encephalitis virus infection. PLoS One (2014) 0.78
Innate Immunity and Immune Evasion by Enterovirus 71. Viruses (2015) 0.77
Herpesviral infection and Toll-like receptor 2. Protein Cell (2012) 0.76
HTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cells. PLoS Pathog (2014) 0.76
The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression. Curr Signal Transduct Ther (2010) 0.76
Immune-Related Gene Expression Patterns in GPV- or H9N2-Infected Goose Spleens. Int J Mol Sci (2016) 0.76
Human Bocavirus NS1 and NS1-70 Proteins Inhibit TNF-α-Mediated Activation of NF-κB by targeting p65. Sci Rep (2016) 0.75
The vesicular stomatitis virus matrix protein inhibits NF-κB activation in mouse L929 cells. Virology (2016) 0.75
Unveiling the pathogen behind the vacuole. Nat Rev Microbiol (2015) 0.75
High-throughput quantitative real-time RT-PCR assay for determining expression profiles of types I and III interferon subtypes. J Vis Exp (2015) 0.75
An Internally Translated MAVS Variant Exposes Its Amino-terminal TRAF-Binding Motifs to Deregulate Interferon Induction. PLoS Pathog (2015) 0.75
New pandemics: HIV and AIDS, HCV and chronic hepatitis, influenza virus and flu. Retrovirology (2007) 0.75
TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Is Essential for MPTP-Induced Dopaminergic Neuroprotection via Microglial Cell M1/M2 Modulation. Front Cell Neurosci (2017) 0.75
Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity. Sci Rep (2017) 0.75
Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis. Ann Am Thorac Soc (2014) 0.75
Supportive care for patients with gastrointestinal cancer. Cochrane Database Syst Rev (2004) 1.55
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res (2001) 1.49
Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway. Cell Mol Biol (Noisy-le-grand) (2006) 1.33
Human immunodeficiency virus infection associated arthritis: clinical characteristics. J Rheumatol (1999) 1.07
Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens. Leukemia (2011) 1.07
Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice. Int J Clin Pract (2011) 1.04
The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia. Leukemia (2013) 0.89
Willingness to pay and conjoint analysis to determine women's preferences for ovarian stimulating hormones in the treatment of infertility in Spain. Hum Reprod (2011) 0.84
Muscular strength and bone mineral density in haemodialysis patients. Nephrol Dial Transplant (1997) 0.83
Hepatitis B virus in Buenos Aires, Argentina: genotypes, virological characteristics and clinical outcomes. Clin Microbiol Infect (2011) 0.81
Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir. J Viral Hepat (2013) 0.81
The experience in nicaragua: childhood leukemia in low income countries-the main cause of late diagnosis may be "medical delay". Int J Pediatr (2012) 0.80
Prevalence and characteristics of rheumatic manifestations in patients infected with human immunodeficiency virus undergoing antiretroviral therapy. J Rheumatol (1997) 0.80
Arterial pressure as a determinant of left ventricular filling pressure after acute myocardial infarction. Am J Cardiol (1974) 0.79
In vitro autoradiographic studies of cell proliferation in the gastrointestinal tract of man. J Nucl Med (1968) 0.78
[Tuberculous peritonitis in HIV-infected patients]. Rev Argent Microbiol (2010) 0.75
[Electromanometric study of the action of metoclopramide in man]. Sem Hop (1969) 0.75
[Lipomatosis of the ileocecal valve]. Acta Gastroenterol Belg (1971) 0.75
[Congenital absence of the left hepatic lobe: 2 cases]. Acta Gastroenterol Belg (1970) 0.75
[Prevalence of chronic bronchitis in an urban and a rural area of Santiago and its relation to the degree of air pollution]. Rev Med Chil (1972) 0.75
Bone mineral density in a native population of Argentina with low calcium intake. J Rheumatol (1995) 0.75
[Treatment of functional megadolichocolons with dihydroergotamine methane sulphonate]. Acta Gastroenterol Belg (1971) 0.75
[Electromanometric studies of normal gut and megadolichocolons after use of dihydroergotamine methane sulphonate]. Acta Gastroenterol Belg (1971) 0.75
[Disorders of gastrointestinal motility in organic pathology of the digestive tract]. Acta Gastroenterol Belg (1967) 0.75
[Edematous hypertrophy of Bauhin's valvule. 3 surgical cases]. Acta Gastroenterol Belg (1967) 0.75